Advertisement

Oral Cancer

What the General Surgeon Should Know
Published:March 05, 2022DOI:https://doi.org/10.1016/j.suc.2021.12.007

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Surgical Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Cancer today.
        (Available at:) (Accessed June 19, 2021)
        • Carvalho A.L.
        • Nishimoto I.N.
        • Califano J.A.
        • et al.
        Trends in incidence and prognosis for head and neck cancer in the United States: A site-specific analysis of the SEER database.
        Int J Cancer. 2005; 114: 806-816
        • Weatherspoon D.J.
        • Chattopadhyay A.
        • Boroumand S.
        • et al.
        Oral cavity and oropharyngeal cancer incidence trends and disparities in the United States: 2000–2010.
        Cancer Epidemiol. 2015; 39: 497-504
        • Osazuwa-Peters N.
        • Massa S.T.
        • Christopher K.M.
        • et al.
        Race and sex disparities in long-term survival of oral and oropharyngeal cancer in the United States.
        J Cancer Res Clin Oncol. 2016; 142: 521-528
        • Kwok J.
        • Langevin S.M.
        • Argiris A.
        • et al.
        The impact of health insurance status on the survival of patients with head and neck cancer.
        Cancer. 2010; 116: 476-485
        • Agarwal P.
        • Agrawal R.R.
        • Jones E.A.
        • et al.
        Social Determinants of Health and Oral Cavity Cancer Treatment and Survival: A Competing Risk Analysis.
        Laryngoscope. 2020; 130: 2160-2165
      2. SEER cancer Statistics Review 1975-2008 - Previous Version - SEER cancer Statistics. SEER.
        (Available at:) (Accessed July 6, 2021)
        • Farhood Z.
        • Simpson M.
        • Ward G.M.
        • et al.
        Does anatomic subsite influence oral cavity cancer mortality? A SEER database analysis.
        The Laryngoscope. 2019; 129: 1400-1406
        • Hashibe M.
        • Brennan P.
        • Benhamou S.
        • et al.
        Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium.
        J Natl Cancer Inst. 2007; 99: 777-789
        • Znaor A.
        • Brennan P.
        • Gajalakshmi V.
        • et al.
        Independent and combined effects of tobacco smoking, chewing and alcohol drinking on the risk of oral, pharyngeal and esophageal cancers in Indian men.
        Int J Cancer. 2003; 105: 681-686
        • Ng S.K.C.
        • Kabat G.C.
        • Wynder E.L.
        Oral Cavity Cancer in Non-Users of Tobacco.
        J Natl Cancer Inst. 1993; 85: 743-745
        • Turati F.
        • Garavello W.
        • Tramacere I.
        • et al.
        A meta-analysis of alcohol drinking and oral and pharyngeal cancers. Part 2: results by subsites.
        Oral Oncol. 2010; 46: 720-726
        • Blot W.J.
        • McLaughlin J.K.
        • Winn D.M.
        • et al.
        Smoking and drinking in relation to oral and pharyngeal cancer.
        Cancer Res. 1988; 48: 3282-3287
        • Macfarlane G.J.
        • Zheng T.
        • Marshall J.R.
        • et al.
        Alcohol, tobacco, diet and the risk of oral cancer: a pooled analysis of three case-control studies.
        Eur J Cancer B Oral Oncol. 1995; 31B: 181-187
        • Goldstein B.Y.
        • Chang S.-C.
        • Hashibe M.
        • et al.
        Alcohol consumption and cancers of the oral cavity and pharynx from 1988 to 2009: an update.
        Eur J Cancer Prev. 2010; 19: 431-465
        • Franceschi S.
        • Levi F.
        • Maso L.D.
        • et al.
        Cessation of alcohol drinking and risk of cancer of the oral cavity and pharynx.
        Int J Cancer. 2000; 85: 787-790
        • Dahlstrom K.R.
        • Little J.A.
        • Zafereo M.E.
        • et al.
        Squamous cell carcinoma of the head and neck in never smoker-never drinkers: a descriptive epidemiologic study.
        Head Neck. 2008; 30: 75-84
        • Wiseman S.M.
        • Swede H.
        • Stoler D.L.
        • et al.
        Squamous Cell Carcinoma of the Head and Neck in Nonsmokers and Nondrinkers: An Analysis of Clinicopathologic Characteristics and Treatment Outcomes.
        Ann Surg Oncol. 2003; 10: 551-557
        • Patel S.C.
        • Carpenter W.R.
        • Tyree S.
        • et al.
        Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years.
        J Clin Oncol. 2011; 29: 1488-1494
        • Ng J.H.
        • Iyer N.G.
        • Tan M.-H.
        • et al.
        Changing epidemiology of oral squamous cell carcinoma of the tongue: A global study.
        Head & Neck. 2017; 39: 297-304
        • Mizuno K.
        • Takeuchi M.
        • Kikuchi M.
        • et al.
        Outcomes in patients diagnosed with tongue cancer before and after the age of 45 years.
        Oral Oncol. 2020; 110: 105010
        • Piemonte E.D.
        • Lazos J.P.
        • Brunotto M.
        Relationship between chronic trauma of the oral mucosa, oral potentially malignant disorders and oral cancer.
        J Oral Pathol Med. 2010; 39: 513-517
        • Vial T.
        • Descotes J.
        Immunosuppressive drugs and cancer.
        Toxicology. 2003; 185: 229-240
        • IARC Working Group on the Evaluation of Carcinogenic Risks to Humans
        Betel-quid and areca-nut chewing and some areca-nut derived nitrosamines.
        IARC Monogr Eval Carcinog Risks Hum. 2004; 85: 1-334
        • Thomas S.J.
        • Bain C.J.
        • Battistutta D.
        • et al.
        Betel quid not containing tobacco and oral cancer: A report on a case–control study in Papua New Guinea and a meta-analysis of current evidence.
        Int J Cancer. 2007; 120: 1318-1323
        • Pan C.
        • Issaeva N.
        • Yarbrough W.G.
        HPV-driven oropharyngeal cancer: current knowledge of molecular biology and mechanisms of carcinogenesis.
        Cancers of the Head & Neck. 2018; 3: 12
        • Amagasa T.
        • Yamashiro M.
        • Uzawa N.
        Oral premalignant lesions: from a clinical perspective.
        Int J Clin Oncol. 2011; 16: 5-14
        • Pinto A.C.
        • Caramês J.
        • Francisco H.
        • et al.
        Malignant transformation rate of oral leukoplakia-systematic review.
        Oral Surg Oral Med Oral Pathol Oral Radiol. 2020; 129: 600-611.e2
        • Shafer W.G.
        • Waldron C.A.
        Erythroplakia of the oral cavity.
        Cancer. 1975; 36: 1021-1028
        • Villa A.
        • Villa C.
        • Abati S.
        Oral cancer and oral erythroplakia: an update and implication for clinicians.
        Aust Dent J. 2011; 56: 253-256
        • Iocca O.
        • Sollecito T.P.
        • Alawi F.
        • et al.
        Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta-analysis of malignant transformation rate by subtype.
        Head Neck. 2020; 42: 539-555
        • Dammann F.
        • Horger M.
        • Mueller-Berg M.
        • et al.
        Rational Diagnosis of Squamous Cell Carcinoma of the Head and Neck Region: Comparative Evaluation of CT, MRI, and 18FDG PET.
        Am J Roentgenology. 2005; 184: 1326-1331
        • Seitz O.
        • Chambron-Pinho N.
        • Middendorp M.
        • et al.
        18F-Fluorodeoxyglucose-PET/CT to evaluate tumor, nodal disease, and gross tumor volume of oropharyngeal and oral cavity cancer: comparison with MR imaging and validation with surgical specimen.
        Neuroradiology. 2009; 51: 677-686
        • Pentenero M.
        • Cistaro A.
        • Brusa M.
        • et al.
        Accuracy of 18F-FDG-PET/CT for staging of oral squamous cell carcinoma.
        Head & Neck. 2008; 30: 1488-1496
        • Sarrión Pérez M.G.
        • Bagán J.V.
        • Jiménez Y.
        • et al.
        Utility of imaging techniques in the diagnosis of oral cancer.
        J Cranio-Maxillofacial Surg. 2015; 43: 1880-1894
        • Xu G.-Z.
        • Guan D.-J.
        • He Z.-Y.
        18)FDG-PET/CT for detecting distant metastases and second primary cancers in patients with head and neck cancer. A meta-analysis.
        Oral Oncol. 2011; 47: 560-565
        • Tirelli G.
        • Gatto A.
        • Boscolo Nata F.
        • et al.
        Prognosis of oral cancer: a comparison of the staging systems given in the 7th and 8th editions of the American Joint Committee on Cancer Staging Manual.
        Br J Oral Maxillofac Surg. 2018; 56: 8-13
        • Moeckelmann N.
        • Ebrahimi A.
        • Tou Y.K.
        • et al.
        Prognostic implications of the 8th edition American Joint Committee on Cancer (AJCC) staging system in oral cavity squamous cell carcinoma.
        Oral Oncol. 2018; 85: 82-86
        • Pollaers K.
        • Hinton-Bayre A.
        • Friedland P.L.
        • et al.
        AJCC 8th Edition oral cavity squamous cell carcinoma staging - Is it an improvement on the AJCC 7th Edition?.
        Oral Oncol. 2018; 82: 23-28
        • Spiro R.H.
        • Huvos A.G.
        • Wong G.Y.
        • et al.
        Predictive value of tumor thickness in squamous carcinoma confined to the tongue and floor of the mouth.
        Am J Surg. 1986; 152: 345-350
        • Bundgaard T.
        • Rossen K.
        • Henriksen S.D.
        • et al.
        Histopathologic parameters in the evaluation of T1 squamous cell carcinomas of the oral cavity.
        Head Neck. 2002; 24: 656-660
        • Zanoni D.K.
        • Montero P.H.
        • Migliacci J.C.
        • et al.
        Survival outcomes after treatment of cancer of the oral caviTY (1985-2015).
        Oral Oncol. 2019; 90: 115-121
      3. Oral Cancer 5-Year Survival Rates by Race, Gender, and Stage of Diagnosis | National Institute of Dental and Craniofacial Research.
        (Available at:) (Accessed July 8, 2021)
        • Gil Z.
        • Carlson D.L.
        • Boyle J.O.
        • et al.
        Lymph node density is a significant predictor of outcome in patients with oral cancer.
        Cancer. 2009; 115: 5700-5710
        • National Comprehensive Cancer Network
        Head and Neck Cancers (Version 3.2021).
        (Available at:) (Accessed July 9, 2021)
        • Smith J.E.
        • Suh J.D.
        • Erman A.
        • et al.
        Risk Factors Predicting Aspiration After Free Flap Reconstruction of Oral Cavity and Oropharyngeal Defects.
        Arch Otolaryngol Head Neck Surg. 2008; 134: 1205
        • Looser K.G.
        • Shah J.P.
        • Strong E.W.
        The significance of “positive” margins in surgically resected epidermoid carcinomas.
        Head Neck Surg. 1978; 1: 107-111
        • Sutton D.N.
        • Brown J.S.
        • Rogers S.N.
        • et al.
        The prognostic implications of the surgical margin in oral squamous cell carcinoma.
        Int J Oral Maxillofac Surg. 2003; 32: 30-34
        • Ganly I.
        • Patel S.
        • Shah J.
        Early stage squamous cell cancer of the oral tongue--clinicopathologic features affecting outcome.
        Cancer. 2012; 118: 101-111
        • Pathak K.A.
        • Nason R.W.
        • Penner C.
        • et al.
        Impact of use of frozen section assessment of operative margins on survival in oral cancer.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009; 107: 235-239
        • Buchakjian M.R.
        • Tasche K.K.
        • Robinson R.A.
        • et al.
        Association of main specimen and tumor bed margin status with local recurrence and survival in oral cancer surgery.
        JAMA Otolaryngol Head Neck Surg. 2016; 142: 1191-1198
        • Mair M.
        • Nair D.
        • Nair S.
        • et al.
        Intraoperative gross examination vs frozen section for achievement of adequate margin in oral cancer surgery.
        Oral Surg Oral Med Oral Pathol Oral Radiol. 2017; 123: 544-549
        • Bulbul M.G.
        • Tarabichi O.
        • Sethi R.K.
        • et al.
        Does clearance of positive margins improve local control in oral cavity cancer? a meta-analysis.
        Otolaryngol Head Neck Surg. 2019; 161: 235-244
        • Pfister D.G.
        • Spencer S.
        • Adelstein D.
        • et al.
        NCCN guidelines insights: head and neck cancers, version 3.
        J Natl Compr Canc Netw. 2021; (Available at:) (Accessed July 9, 2021)
      4. Recommendations | Cancer of the upper aerodigestive tract: assessment and management in people aged 16 and over | Guidance | NICE.
        (Accessed)
        • D’Cruz A.K.
        • Vaish R.
        • Kapre N.
        • et al.
        Elective versus therapeutic neck dissection in node-negative oral cancer.
        N Engl J Med. 2015; 373: 521-529
        • Hutchison I.L.
        • Ridout F.
        • Cheung S.M.Y.
        • et al.
        Nationwide randomised trial evaluating elective neck dissection for early stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort.
        Br J Cancer. 2019; 121: 827-836
        • Melchers L.J.
        • Schuuring E.
        • van Dijk B.A.C.
        • et al.
        Tumour infiltration depth ⩾4mm is an indication for an elective neck dissection in pT1cN0 oral squamous cell carcinoma.
        Oral Oncol. 2012; 48: 337-342
        • van Lanschot C.G.F.
        • Klazen Y.P.
        • de Ridder M.A.J.
        • et al.
        Depth of invasion in early stage oral cavity squamous cell carcinoma: The optimal cut-off value for elective neck dissection.
        Oral Oncol. 2020; 111: 104940
        • Scher E.D.
        • Romesser P.B.
        • Chen C.
        • et al.
        Definitive chemoradiation for primary oral cavity carcinoma: A single institution experience.
        Oral Oncol. 2015; 51: 709-715
        • Spiotto M.T.
        • Jefferson G.
        • Wenig B.
        • et al.
        Differences in survival with surgery and postoperative radiotherapy compared with definitive chemoradiotherapy for oral cavity cancer: a national cancer database analysis.
        JAMA Otolaryngology Head Neck Surg. 2017; 143: 691-699
        • Foster C.C.
        • Melotek J.M.
        • Brisson R.J.
        • et al.
        Definitive chemoradiation for locally-advanced oral cavity cancer: A 20-year experience.
        Oral Oncol. 2018; 80: 16-22
        • Sasaki M.
        • Aoki T.
        • Karakida K.
        • et al.
        Postoperative follow-up strategy in patients with oral squamous cell carcinoma.
        J Oral Maxillofac Surg. 2011; 69: e105-e111
        • Brands M.T.
        • Smeekens E.A.J.
        • Takes R.P.
        • et al.
        Time patterns of recurrence and second primary tumors in a large cohort of patients treated for oral cavity cancer.
        Cancer Med. 2019; 8: 5810-5819